Satsuma Pharmaceuticals Inc (STSA)
US80405P1075 - Common Stock
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -64.83M | -70.06M | -51.17M | -47.56M | -28.18M | |||
| Depreciation Amortization | 418.00K | 510.00K | 393.00K | 240.00K | 140.00K | |||
| Change In Working Capital | -1.18M | 367.00K | 1.10M | 790.00K | -2.36M | |||
| Interest Paid | 3.00K | 14.00K | 126.00K | 260.00K | 350.00K | |||
| Taxes Paid | N/A | 0.00 | -5.00K | 0.00 | 10.00K | |||
| Other non cash items | 17.01M | 17.66M | 6.68M | 4.20M | 760.00K | |||
| OPERATING CASH FLOW | -48.58M | -51.52M | -43.00M | -42.33M | -29.64M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -448.00K | -472.00K | -2.03M | -5.17M | -550.00K | |||
| Other Investing Activity | 37.96M | 43.84M | -48.75M | 63.16M | -95.33M | |||
| INVESTING CASH FLOW | 37.51M | 43.37M | -50.78M | 58.00M | -95.88M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -583.00K | -1.08M | -2.00M | -2.00M | -170.00K | |||
| Stock Issued/Repurchased | N/A | 122.00K | 68.00K | 130.00K | 143.23M | |||
| Other Financing Activity | N/A | 9.70M | 75.22M | -240.00K | N/A | |||
| FINANCING CASH FLOW | 9.24M | 8.74M | 73.28M | -2.10M | 143.06M | |||
| CHANGE IN CASH | -1.83M | 594.00K | -20.49M | 13.57M | 17.54M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -48.58M | -51.52M | -43.00M | -42.33M | -29.64M | |||
| Capital Expenditure | -448.00K | -472.00K | -2.03M | -5.17M | -550.00K | |||
| FREE CASH FLOW | -49.03M | -51.99M | -45.03M | -47.50M | -30.19M | |||
All data in USD